Democratic Lawmakers Attempt to Extend Medicare Prescription Drug Subsidy

Two Democratic lawmakers have introduced a bill to reinstate a Medicare program previously discontinued by the Trump administration. Representatives Kathy Castor of Florida and Terri Sewell of Alabama have unveiled the Affordable Premiums for Seniors Act. This legislation seeks to extend the Medicare Part D Premium Stabilization Demonstration until 2029. Recently, the Trump administration declared the Centers for Medicare & Medicaid Services (CMS) would end the program by the end of next year.

Representative Castor emphasized, “Every trip to the grocery store and every monthly bill is increasingly painful for my older neighbors. The added strain of higher prescription drug costs is the last thing they need, so I will fight to reverse a recent HHS scheme to increase Medicare prescription drug costs for seniors and people with disabilities.” She further explained that the Affordable Premiums for Seniors Act aims to reverse this scheme, maintain lower premiums, and provide more certainty for healthcare costs. Castor stressed the importance of keeping Medicare benefits affordable and dependable for seniors who have worked hard for these earned benefits.

Why It Matters

The Kaiser Family Foundation (KFF) reports that nearly 25 million people were enrolled in standalone Medicare Part D prescription drug plans in 2026. Without the stabilization program, some beneficiaries could face significant premium increases in 2027, more substantial than those experienced in recent years. Retirees living on fixed incomes already grapple with rising housing and healthcare costs. By maintaining the subsidy, lawmakers argue that drug coverage could remain more affordable. However, the Trump administration claimed that these extra subsidies are no longer necessary.

What to Know

The Affordable Premiums for Seniors Act aims to prevent CMS from ending the Medicare Part D Premium Stabilization Demonstration. Instead, it seeks to continue the program through 2029. CMS initially introduced the subsidy in 2025 following changes made under the Inflation Reduction Act, which redesigned Medicare’s prescription drug benefit. These reforms included a $2,000 annual cap on out-of-pocket prescription drug costs and shifted a greater share of costs onto Part D plans. Finance expert Michael Ryan noted, “This is about what they pay each month for standalone Part D drug coverage. The stabilization program absorbed some of the shock while insurers adjusted to major changes in Medicare Part D. Ending it removes that cushion.”

Ryan highlighted that for those living on a fixed income, even an additional $10 or $20 a month is significant. Many support extending the demonstration program, arguing it prevented sharp premium increases and gave seniors more predictable costs. Kevin Thompson, CEO of 9i Capital Group, stated, “Lowering premiums for people at the lower end of the income spectrum, particularly those who rely heavily on prescription drugs, is a definite benefit for beneficiaries living on fixed incomes.” However, he noted the concern that insurers are subsidized to keep premiums down, rather than addressing the underlying prescription drug and healthcare costs.

According to the Medicare Payment Advisory Commission (MedPAC), the subsidy saved seniors an average of $312 in 2026. Representative Sewell emphasized, “Ending the Part D Premium Stabilization Program could mean higher premiums and greater financial strain for millions of seniors. The Affordable Premiums for Seniors Act will help ensure that Medicare beneficiaries have the stability and certainty they deserve.”

How the Medicare Part D Premium Stabilization Program Worked

CMS announced plans to end the demonstration program after assessing 2027 plan bids, concluding that insurers had sufficient experience operating under the redesigned Part D benefit. Mehmet Oz, administrator of CMS, defended the decision, arguing that the additional subsidies were unnecessary bailouts for insurers, asserting, “We are stabilizing the market so this bailout is no longer needed.” Oz indicated that premiums would increase by less than $10 for most Medicare recipients, with many experiencing even lower premiums.

CMS has announced the national base beneficiary premium for Medicare Part D will be $41.33 in 2027, although final premium information will be released later this year. Michael Ryan noted, “The question moving forward is whether the market is actually ready to lose the training wheels.”

What Happens Next

The bill faces an uncertain path in Congress, currently controlled by Republicans. It requires approval from both chambers before reaching President Donald Trump’s desk. Meanwhile, Medicare beneficiaries await final 2027 Part D premium announcements, providing a clearer picture of potential prescription drug coverage costs after the stabilization program’s end. Thompson concluded, “Democrats simply don’t have the votes, and Republicans currently hold congressional power. Without bipartisan support, extending the subsidy will be difficult.”